drugset / Trial / NCT00583258

A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones

NCT00583258

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Patients who present for the first time to Emergency Room with renal colic due to a distal ureteral calculus (as diagnosed with spiral CT scan and KUB) will be randomized to receive Xatral 10mg po once a day or placebo once discharged from the ER. The purpose of this study is to assess if patients treated with Xatral will have a higher spontaneous passage rate of their ureteral stone than those treated with placebo.

Timeline

Start
2007-10
Primary completion
2009-09
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfuzosin Small molecule 10 mg Oral

Indications